Loading...
BVMF
DASA3
Market cap1.20bUSD
Oct 08, Last price  
4.89BRL
1D
1.66%
1Q
85.93%
Jan 2017
-72.38%
IPO
-16.71%
Name

Diagnosticos da America SA

Chart & performance

D1W1MN
BVMF:DASA3 chart
P/E
—
P/S
0.55
EPS
—
Div yield, %
—
Shrs. gr., 5y
21.16%
Rev. gr., 5y
9.67%
Revenues
11.17b
-27.10%
670,450,000858,820,0001,137,525,0001,388,313,0001,501,967,0002,179,874,0002,264,142,0002,447,782,0002,697,573,0002,794,399,0003,040,775,0003,399,308,0003,933,451,0004,364,585,0007,039,331,00010,418,674,00013,128,893,00014,252,235,00015,322,079,00011,170,362,000
Net income
-1.15b
L-3.92%
16,511,00056,621,000-12,054,00099,408,00097,966,000145,455,00085,192,000131,301,00082,289,00023,813,00094,738,000131,443,000184,378,000124,777,000-150,802,000-226,569,000-386,924,000-1,166,016,000-1,198,990,000-1,151,989,000
CFO
-36m
L
132,873,00090,406,000279,039,00096,457,000195,293,000247,548,000310,421,000254,980,000459,222,000489,386,000841,937,000653,235,000530,331,000699,366,000766,504,0001,298,179,000-28,999,000-963,624,00027,946,000-36,349,000
Dividend
Dec 27, 20220.097 BRL/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.

Key people

Pedro De Godoy Bueno
Vice Chairman of the Board · since 2023
Helisson Brigido Andrade Lemos
Vice President of Marketing and Products · since 2024
Andre Covre
Vice President of Corporate Strategy · since 2024
Roberto Cury
Vice President of Service Units and NAC · since 2024
Anaterra Ddd
Vice President of IT · since 2024
Fabio Sampaio De Lacerda
Vice President of People, Management and Culture · since 2025
Leonardo Vedolin
Vice President Medical and Production Director · since 2024
Rafael Bossolani
Vice President of Finance and Investor Relations · since 2024
Rafael Lucchesi
Director of President · since 2025
Linaldo Vilar
Production Director · since 2023
Dulce De Godoy Bueno
Chairman of the Board · since 2023
Henrique Gross
Director · since 2021
Maria Leticia De Freitas Costa
Independent Director · since 2023
Oscar de Paula Bernardes N
Independent Director · since 2023
Romeu Domingues
Independent Director · since 2023
Stelleo Tolda
Independent Director · since 2022
URL
https://dasa.com.br/
IPO date
Nov 19, 2004
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT